1. Yang Liu, Shaojie Zhai, Xingwu Jiang*, Yanyan Liu, Kun Wang, Chaochao Wang, Meng Zhang, Xuanyong Liu*, Wenbo Bu*. Intracellular mutual promotion of redox homeostasis regulation and iron metabolism disruption for enduring chemodynamic therapy. [J]. Advanced Functional Materials, 2021, 2010390.
2. Yifei Yin#, Xingwu Jiang#, Liping Sun#, Hongyan Li, Chunxia Su, Yan Zhang, Guang Xu, Xiaolong Li, Chongke Zhao, Yu Chen*, Huixiong Xu*, Kun Zhang*. Continuous inertial cavitation evokes massive ROS for reinforcing sonodynamic therapy and immunogenic cell death against breast carcinoma[J]. Nano Today, 2021, 36: 101009.
3.BeiEr Jiang#, Xingwu Jiang#, Qiansen Zhang, Qiuwen Liang, Zi-Liang Qiu, Xiang-Bai Sun, Jun-Jie Yang, Si Chen, Chunyang Yi, Xiaolei Chai, Mingyao Liu, Li-Fang Yu*, Weiqiang Lu*, Han-Kun Zhang*.From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis[J]. Journal of Medicinal Chemistry, 2021 Jan 14;64(1):385-403.
4. Xingwu Jiang#, Si Chen#, Qiansen Zhang, Chunyang Yi, Jiacheng He, Xiyun Ye, Mingyao Liu, Weiqiang Lu*. Celastrol is a novel selective agonist of cannabinoid receptor 2 with anti-inflammatory and anti-fibrotic activity in a mouse model of systemic sclerosis[J]. Phytomedicine.2020, Feb;67:153160.
5. XingWu Jiang#, BeiEr Jiang#, Hao Liu, ZhiTao Liu, LongLong Hu, Mingyao Liu, Weiqiang Lu, HanKun Zhang, Design, synthesis, and biological evaluations of phenylpropiolic acid derivatives as novel GPR40 agonists [J].European Journal of Medicinal Chemistry, 2018 Oct 5;158:123-133.
6. Xingwu Jiang#, Weiqiang Lu#, Xiaoyang Shen#, Quan Wang, Jing Lv, Mingyao Liu, Feixiong Cheng*, Zhongming Zhao*, Xiufeng Pang*. Repurposing sertraline sensitizes non–small cell lung cancer cells to erlotinib by inducing autophagy [J]. JCI insight, 2018, 3(11).